ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia

por Currow, D., Temel, J. S., Abernethy, A., Milanowski, J., Friend, J., Fearon, K. C.
Publicado 2017